Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00489164 · ClinicalTrials.gov registry record · Phase 1
Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions
A Phase 1 study, sponsored by Cordis US.
- Terminated
- Registry status
- Phase 1
- Development phase
- 83
- Enrollment target
NCT00489164 is a Phase 1 study that was terminated before completion, run by Cordis US. The registered enrollment target is 83 participants.
The verdict
NCT00489164, a Phase 1 study, was terminated before completion, sponsored by Cordis US.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 83 participants
- Enrollment target
Study Summary
The main objective of this study is to assess in-stent late lumen loss in diabetic patients with de novo native coronary lesions using the sirolimus-eluting Bx VELOCITYä stent as compared to the Bx VELOCITY balloon-expandable stent.
Interventions
- DEVICE Sirolimus-Eluting BX Velocity Balloon-Expandable Stent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2002-08 |
| Est. Completion | 2004-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00489164
The ClinicalTrials.gov registry entry for NCT00489164 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cordis US, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sirolimus-Eluting BX Velocity Balloon-Expandable Stent is the first listed.
NCT00489164 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00489164 about?
NCT00489164 is a clinical study titled "Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions". The main objective of this study is to assess in-stent late lumen loss in diabetic patients with de novo native coronary lesions using the sirolimus-eluting Bx VELOCITYä stent as compared to the Bx VELOCITY balloon-expandable stent.
What is the current status of trial NCT00489164?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 83 participants. The study started on 2002-08. Estimated completion is 2004-05.
What interventions are being tested in trial NCT00489164?
The interventions under investigation include: Sirolimus-Eluting BX Velocity Balloon-Expandable Stent (DEVICE).
Who is sponsoring clinical trial NCT00489164?
This trial is sponsored by Cordis US, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.